Welcoming message given by Sonia Wallman, of the Organizing Committee, and Lance Hartford, the Executive Director of the Massachusetts Biotechnology Education Foundation.
2. Annual Community College Program Day
Organizing Committee
• Sonia Wallman – Executive Director NBC2
• Elaine Johnson – Bio-Link Director
• Russ Read – National Center, NC BioNetwork
• Lance Hartford – MassBioEd Foundation
• Margaret Bryans – PI NBC2, Montgomery County
Community College
• Lisa Seidman – Madison Area Technical College
• Tim Dubuque - NBC2
3.
4. Massachusetts BioPharma Employment
Continues Growth
The industry
weathered
the 2009
downturn
without an
employment
drop.
53%
Growth
since
Source: U.S. Census, County Business Patterns and MassBio formula and analysis.
2002 *2011 figure is a preliminary estimate based on review of Massachusetts ES-202 data for 2010-2011.
5. Biotechnology R&D Employment
2007 2010
According to the
Bureau of Labor
CA 19,134 21,616
Statistics’ CT 2,452 1,582
Quarterly Census MA 24,565 26,807
of Employment &
Wage (QCEW) MD 10,154 9,469
data, Massachus MI 4,670 2,759
etts leads the
nation in MO 4,262 3,874
biotechnology NJ 8,567 9,224
research &
development
NY 2,679 3,553
employment. NC 7,042 6,275
PA 15,902 12,776
WA 2,499 3,730
Source: U.S. Bureau of Labor Statistics, Quarterly Census of Employment and Wages (QCEW)
6. Drug Development Pipeline, August 2011
Candidate medicines of Massachusetts-headquartered* companies, by clinical trials
stage
Pre-Clinical 316
Massachusetts-
Phase I 216
headquartered
companies* Phase II 275
account for about Phase III 76
10% of the U.S. Pending Approval 14
drug development
pipeline and 5% Massachusetts-headquartered companies’ share of U.S. and Global drug
of the global development pipeline
pipeline.
Total Trials PC I II III PA
% of US 9.41% 11.00% 11.99% 8.26% 8.46% 3.89%
% of Global 4.91% 5.88% 6.43% 4.56% 3.52% 1.44%
* There are many drugs in development in Massachusetts by companies with headquarters
located outside of Massachusetts. These candidate drugs are not included in any
Massachusetts pipeline estimates found in this report.
Source: MedTrack Online, Life Sciences Analytics, Inc.
7. Massachusetts Pipeline by Therapeutic
Area
Total Trials Companies
Of the 897 drugs in Cancer 383 59
the Massachusetts Central Nervous System 91 35
pipeline, 42.7% Infectious 84 30
are cancer drugs. Autoimmune and Inflammation 61 33
Metabolic/Endocrinology 47 23
Drugs intended for Ophthalmology and Optometry 32 13
the Central Respiratory and Pulmonary System 32 20
Nervous System Blood and Lymphatic System 30 16
(CNS) therapeutic Cardiovascular & Circulatory 25 36
area are next at Musculo-Skeletal-Disorders 24 11
10.1% of the Digestive 19 15
pipeline. Dermotology 18 15
Kidney & Genito-Urinary 13 10
Genetic Diseases & Dysmorphic Syndromes 11 6
Substance Abuse 10 5
Women's Health 9 6
Miscellaneous 8 7
Source: MedTrack Online, Life Sciences Analytics, Inc.
8. Venture Capital Investment
$1.071 billion
invested in MA
biotechs in 2011
is an historic
high.
$8.054
billion since
2002
Source Data: 2011 PricewaterhouseCoopers, National Venture Capital Association, MoneyTreeTM Report, Historical Trend Data, and
MassBio analysis.
9. MA Share of the Biotech VC Dollar
MA biotechs
received 22.6%
of all VC biotech
financing, just
below the 2010
all-time high.
Source: 2011 PricewaterhouseCoopers, National Venture Capital
Association, MoneyTreeTM Report, Historical Trend Data, MassBio analysis.
10. Leading BioPharma Employers (MA), 2011
1. Genzyme (Sanofi) 4,356
2. Pfizer 2,600
3. Biogen Idec 2,300
4. Novartis 2,100
MA has benefited 5. Thermo Fisher Scientific 1,700
from the pharma 6. Shire 1,500
industry’s 7. Vertex 1,310
embrace of 8. EMD Millipore 1,237
biotechnology. 9. Parexel International 1,200
10. Millenium: Takeda Oncology 1,050
11. Charles River Laboratories 970
12. AstraZeneca 900
13. EMD Serono 850
14. Hologic 800
15. Abbott Laboratories 750
16. Sunovion Pharmaceuticals (DSP) 690
17. Nova Biomedical 631
18. Cubist 626
19. Lantheus 550
19. Merck 330
20. Bristol-Myers Squibb 320
Sources: MassBio, membership reports, survey, Boston Business Journal Book of Lists, 2011.
11. Mass Biomanufacturing
Of the top 11
biopharma
manufacturing
states, Massachu
setts was one of
just four which
added
manufacturing
jobs in the last
decade
12. BioPharma Industry Impact in MA
The estimated
average
salary in the
biopharma
industry is $4,615,364,513 in payroll (2010)
77% higher
than the
estimated
$95,628 in average salary (2010)
state average
salary of
$53,834. Source: U.S. Census, County Business Patterns, MassBio estimate using 2009 base data .
M a s s a c h u s e tts E x p o rts , 2 0 1 0
A ll C o m m o d itie s 2 6 ,2 5 6 ,3 7 0 ,2 0 1
O p tic , P h o to E tc , M e d ic O r S u rg ic a l In s trm e n ts E tc 5 ,3 2 4 ,5 1 1 ,9 4 0 2 0 .2 0 %
In d u s tria l M a c h in e ry, In c lu d in g C o m p u te rs 4 ,6 0 1 ,7 1 5 ,0 8 6
E le c tric M a c h in e ry E tc ; S o u n d E q u ip ; T v E q u ip ; P ts 4 ,5 1 8 ,6 6 2 ,8 8 0
P h a rm a c e u tic a l P ro d u c ts 2 ,1 3 6 ,3 0 6 ,4 5 6 8 .1 0 %
Source: MassExport Center
13. Why Massachusetts?
500+
430+
Biopharma
Biotech
Companies
122 Top 5
Top
5
NIH funded
Colleges & NIH funded
Research
Universities Research
Hospitals
Hospitals
1st in 1st in
Venture Capital
Education
& SBIR funds
federal research
Level of
funds per worker
per worker
Workforce
workforce (US)
Supportive
Local, State Government
Life Sciences Initiative
Biotech Caucus
14. The $1 Billion Massachusetts Life
Sciences Initiative
Over time, the
industry
demonstrated its
value, commitme
nt to the
region, and
promise for the
future . . . and
state government
responded. • 10 years
• $1 billion
Investment
15. Education and Workforce Development
Initiatives
U.S. Department of Labor to receive the Trade Adjustment Assistance
Community College and Career Training Grant. $20M
The Metro Boston Skilled Careers in Life Sciences (SCILS) initiative $5M – Life
Sciences Center & Quincy College
Mass Life Science Center Internship Program - since the program first launched
in 2009, the Center has placed 794 interns at more than 250 companies
throughout Massachusetts!
MassBioEd Foundation’s industry endorsement of eight community college
programs
Representatives of many of the Massachusetts community colleges are present here today: Middlesex CC, Minuteman Technical Institute, Mount Wachusett CC, Quincy College, Roxbury CC, Springfield Tech, Northern Essex CC, Massasoit CC, Berkshire CC, Bristol CC, Bunker Hill CC, and Holyoke CC. In addition, many other community colleges in the Northeastern US are represented, including Great Bay CC in NH; the Community College of RI; Manchester CC in CT; Hudson Valley CC in NY; Middlesex County and Bergen CC in NJ, and last but not least Bucks and Montgomery County CC in PA. Maggie Bryans is the Principal Investigator of the NBC2 and has put this meeting together for all of us.There are several partners from industry here, as well: former student and biomanufacturing apprentice, David Haddad at Millennium Pharmaceuticals, priceless colleague from engaged partner Lonza, Ben Locwin; harmonization of skill standards and strategic planning meeting participant, John Sauers from Abbott and Bill Chambrione from Shire who has supported the new 360hr/12 week adult biomanufacturing certificate at Minuteman Technical Institute. Welcome to all and back to Lance and Russ to lead our first panel, Industry – Realities and Expectations.